Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124645312 | 12464531 | 2 | F | 200701 | 20160620 | 20160614 | 20160701 | EXP | BR-EMD SERONO-7074171 | EMD SERONO INC | 39.32 | YR | F | Y | 0.00000 | 20160701 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124645312 | 12464531 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | U | Y17A5704 | 103780 | 22 | UG | INJECTION | TIW | |||||
124645312 | 12464531 | 2 | SS | REBIF | INTERFERON BETA-1A | 1 | U | Y17A5704 | 103780 | ||||||||||
124645312 | 12464531 | 3 | C | RIVOTRIL | CLONAZEPAM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124645312 | 12464531 | 1 | Relapsing-remitting multiple sclerosis |
124645312 | 12464531 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124645312 | 12464531 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124645312 | 12464531 | Gamma-glutamyltransferase increased | |
124645312 | 12464531 | Injection site erythema | |
124645312 | 12464531 | Injection site pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124645312 | 12464531 | 1 | 20070107 | 0 |